IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5

Genes and Immunity

Volumn 8, Issue 6, 2007, Pages 503-512

  Shin, J H ^a   Janer, M ^b   McNeney, B ^a   Blay, S ^a   Deutsch, K ^b   Sanjeevi, C B ^c   Kockum, I ^c   Lernmark, A ^d   Graham, J ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PANCREAS ISLET CELL ANTIBODY 2; PROTEIN GIMAP5; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYADENYLATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

ADOLESCENT; ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GTP-BINDING PROTEINS; HUMANS; INFANT; INFANT, NEWBORN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN;

RATTUS;

EID: 34548499874     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364413     Document Type: Article

References (63)

1. Hirschhorn JN. Genetic epidemiology of type 1 diabetes. Pediatr Diabetes 2003; 4: 87-100.
2. Lorenzen T, Pociot F, Hougaard P, Nerup J. Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 1994; 37: 321-327.
3. Davis JA. Insulin dependent diabetes mellitus in twins. Differences between monozygotic and dizygotic twins may need to be taken into account. BMJ 1996; 312: 313-314.
4. Dahlquist G, Blom L, Tuvemo T, Nyström L, Sandstrom A, Wall S. The Swedish childhood diabetes study - results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 1989; 32: 2-6.
5. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000; 355: 873-876.
6. Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature 2001; 414: 792-798.
7. Risch N. Genetics of IDDM: Evidence for complex inheritance with HLA. Genet Epidemiol 1989; 6: 143-148.
8. Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F et al. Type 1 diabetes: Evidence for susceptibility loci from four genome-wide linkage scans in 1435 multiplex families. Diabetes 2005; 54: 2995-3001.
9. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984; 33: 176-183.
10. Barratt BJ, Payne F, Lowe CE, Hermann R, Healy BC, Harold D et al. Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 2004; 53: 1884-1889.
11. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996; 5: 1075-1080.
12. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
13. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36: 337-338.
14. Roach JC, Deutsch K, Li S, Siegel AF, Bekris LM, Einhaus DC et al. Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. Am J Hum Genet 2006; 79: 614-627.
15. Rich SS, Concannon P, Erlich H, Julier C, Morahan G, Nerup J et al. The type 1 diabetes genetics consortium. Ann NY Acad Sci 2006; 1079: 1-8.
16. Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 2001; 69: 820-830.
17. Nerup J, Pociot F, European Consortium for IDDM Studies. A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions. Am J Hum Genet 2001; 69: 1301-1313.
18. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678.
19. Notkins AL, Lernmark A. Autoimmune type 1 diabetes: Resolved and unresolved issues. J Clin Invest 2001; 108: 1247-1252.
20. Wicker LS, Todd JA, Prins JB, Podolin PL, Renjilian RJ, Peterson LB. Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes. J Exp Med 1994; 180: 1705-1713.
21. MacMurray AJ, Moralejo DH, Kwitek AE, Rutledge EA, Van Yserloo B, Gohlke P et al. Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res 2002; 12: 1029-1039.
22. Wicker LS, Chamberlain G, Hunter K, Rainbow D, Howlett S, Tiffen P et al. Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J Immunol 2004; 173 164-173.
23. Colle E, Guttmann RD, Seemayer T. Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex. J Exp Med 1981; 154: 1237-1242.
24. Hornum L, Romer J, Markholst H. The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. Diabetes 2002; 51: 1972-1979.
25. Beaudoing E, Freier S, Wyatt JR, Claverie JM, Gautheret D. Patterns of variant polyadenylation signal usage in human genes. Genome Res 2000; 10: 1001-1010.
26. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. Springer: New York 2001.
27. Ott J. Association of genetic loci: Replication or not, that is the question. Neurology 2004; 63: 955-958.
28. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 96 434-442.
29. Payne F, Smyth DJ, Pask R, Barratt B, Cooper J, Twells R et al. Haplotype tag single nucleotide polymorphism analysis of the human orthologues of the rat type 1 diabetes genes Ian4 (Lyp/Iddm1) and Cblb. Diabetes 2004; 53: 505-509.
30. Decochez K, Truyen I, van der Auwera B, Weets I, Vandemeulebroucke E, de Leeuw IH et al. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes. Diabetologia 2005; 48: 687-694.
31. Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002; 51: 1346-1355.
32. Hellquist A, Zucchelli, M, Kivinen K, Saarialho-Kere U, Koskenmies S, Widen E et al. The human GIMAP5 gene has a common polyadenylation polymorphism increasing risk to systemic lupus erythematosus (SLE). J Med Genet 2007; 44: 314-321.
33. Edwalds-Gilbert G, Veraldi K, Milcarek C. Alternative poly(A) site selection in complex transcription units: Means to an end? Nucl Acids Res 1997; 25: 2547-2561.
34. Conne B, Stutz A, Vassalli JD. The 3′ untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med 2000; 6: 637-641.
35. Sandal T, Aumo L, Hedin L, Gjertsen BT, Doskeland SO. Irod/Ian5: An inhibitor of (gamma)-radiation- and okadaic add-induced apoptosis. Mol Biol Cell 2003; 14: 3292-3304.
36. Nitta T, Nasreen M, Seike T, Goji A, Ohigashi I, Miyazaki T et al. IAN family critically regulates survival and development of T lymphocytes. PLoS Biol 2006; 4: E103.
37. Dalberg U, Markholst H, Hornum. L. Both Gimap5 and the diabetogenic BBDP allele of Gimap5 induce apoptosis in T cells. Int Immunol 2007; 19: 447-453.
38. Pihoker C, Gilliam LK, Hampe CS, Lernmark Å. Autoantibodies in diabetes. Diabetes 2005; 54 (Suppl 2): S52-S61.
39. Nitta T, Takahama Y. The lymphocyte guard-IANs: Regulation of lymphocyte survival by IAN/GIMAP family proteins. Trends Immunol 2007; 28 58-65.
40. Hermann R, Laine AP, Veijola R, Vahlberg T, Simell S, Lahde J et al. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity. Diabetologia 2005; 48: 1766-1775.
41. Hermann R, Lipponen K, Kiviniemi M, Kakko T, Veijola R, Simell O et al. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 2006; 49: 1198-1208.
42. Landin-Olsson M, Karlsson FA, Lernmark Å, Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes 1992; 41: 1022-1027.
43. Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark Å. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur J Immunogenet 1999, 26: 361-372.
44. Sanjeevi CB, Lybrand TP, DeWeese C, Landin-Olsson M, Kockum I, Dahlquist G et al. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study. Diabetes 1995; 44: 125-131.
45. Hubley R, Zitzler E, Siegel A, Roach J. Multiobjective genetic marker selection. Advances in Nature-Inspired Computation: The PPSN VII Workshops 2002; 7: 32-33.
46. Jurinke C, van den Boom D, Cantor CR, Koster H. Automated genotyping using the DNA MassArray technology. Methods Mol Biol 2002, 187 179-492.
47. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-1339.
48. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995; 95: 1505-1511.
49. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 1993; 91: 368-374.
50. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344-350.
51. Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T et al. Radioiummunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19: 113-125.
52. Mire-Sluis AR, Gaines Das R, Lernmark Å. The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia 2000; 43: 1282-1292.
53. Lan MS, Lu J, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994; 13: 505-514.
54. Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA. Cloning and expression of IDDM-specific human autoantigens. Diabetes 1992; 41: 183-186.
55. Kawasaki E, Eisenbarth GS, Wasmeier C, Hutton JC. Auto-antibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2. Diabetes 1996; 45: 1344-1349.
56. Olsson ML, Sundkvist G, Lernmark Å. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 327-332.
57. Bonifacio E, Lernmark Å, Dawkins RL. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 1988; 106: 83-88.
58. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2006, ISBN 3-900051-07-0, htttp://www.R-project-org.
59. Warnes G, Leisch F. Genetics: Population Genetics 2005, R package version 1.2.0.
60. Shin J-H, Blay S, McNeney B, Graham J. LDheatmap: An R function forgraphical display of pairwise linkage disequilibria between single nucleotide polymorphisms. J Stat Soft 2006; 16: Code Snippet 3, http://www.jstatsoft.org/v16/c03/v16c03.pdf.
61. Pritchard JK, Przeworski M. Linkage disequilibrium in humans: Models and data. Am J Hum Genet 2001; 69: 1-14.
62. Kent WJ, Sugnet CW, Furey TS, Roskin KM Pringle TH, Zahler AM et al. The human genome browser: At UCSC. Genome Res 2002; 12: 996-1006.
63. Zhang H, Hu J, Recce M, Tian B. PolyA_DB: A database for mammalian mRNA polyadenylation. Nucleic Acids Res 2005; 33 (Database issue): D116-D120.